MyAverix Finance
KQ · Healthcare
Genome & Company (314130)
Biotechnology
Genome & Company (314130) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 314130
Genome & Company (314130) — FAQ
What is 314130's P/E ratio?
The price-to-earnings (P/E) ratio for Genome & Company (314130) is 25.00 (data as of 2026-05-24).
Does Genome & Company pay a dividend?
Dividend yield is not available in the current snapshot for Genome & Company (314130). Check the MyAverix Finance app for the latest dividend data.
What sector is Genome & Company in?
Genome & Company (314130) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 314130 listed on?
314130 is listed on KQ.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.